Cargando…

Haemophilus influenzae blood-stream infection and third-generation cephalosporin susceptibility testing: a comparative case study using EUCAST and CLSI guidelines

INTRODUCTION. In this comparative case study, we discuss clinically relevant discrepancies of antimicrobial susceptibility testing (AST) interpretation for ceftriaxone against a non-typable, beta-lactamase negative, ampicillin-resistant (BLNAR) Haemophilus influenzae isolated from a blood culture. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merlino, John, Rizzo, Sophia, English, Suzanne, Baskar, Sai Rupa, Siarakas, Steven, Mckew, Genevieve, Fernanado, Shelanah, Gray, Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634490/ https://www.ncbi.nlm.nih.gov/pubmed/37970074 http://dx.doi.org/10.1099/acmi.0.000578.v4

Ejemplares similares

Prevalence of susceptibility patterns of opportunistic bacteria in line with CLSI or EUCAST among Haemophilus parainfluenzae isolated from respiratory microbiota
por: Kosikowska, Urszula, et al.
Publicado: (2020)

Time to switch from CLSI to EUCAST? A Southeast Asian perspective
por: Cusack, T.P., et al.
Publicado: (2019)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
por: Cusack, T.P., et al.
Publicado: (2019)

Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
por: Sachu, Arun
Publicado: (2023)

Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines
por: Dabas, Yubhisha, et al.
Publicado: (2017)

Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms
por: Wolfensberger, Aline, et al.
Publicado: (2013)

1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol
por: Yamano, Yoshinori, et al.
Publicado: (2020)

In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
por: Jang, Min Joong, et al.
Publicado: (2013)

Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement
por: Gaur, Priyanka, et al.
Publicado: (2023)

CLSI announces availability of new CLSI microbiology documents
Publicado: (2007)

1597. Evaluation of Ceftaroline Resistance (CPT-R) in Chile Across Time and a Comparison of CLSI vs. EUCAST Breakpoints in Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Khan, Ayesha, et al.
Publicado: (2019)

In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
por: Rivero-Menendez, Olga, et al.
Publicado: (2021)

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates
por: Pfaller, Michael A., et al.
Publicado: (2016)

Instruction videos from EUCAST
Publicado: (2020)

Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
por: Phan, Thuy, et al.
Publicado: (2022)

Wound infection caused by Neisseria zoodegmatis, a zoonotic pathogen: a case report
por: Merlino, John, et al.
Publicado: (2021)

Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility
por: Kahlmeter, Gunnar, et al.
Publicado: (2020)

Third-generation cephalosporin resistance in Shigella sonnei, Argentina.
por: Radice, M, et al.
Publicado: (2001)

Third-Generation Cephalosporin–Resistant Vibrio cholerae, India
por: Mandal, Jharna, et al.
Publicado: (2012)

Susceptibility of Dermatophytes to Thiabendazole Using CLSI Broth Macrodilution
por: Robledo-Leal, Efrén, et al.
Publicado: (2012)

A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC
por: de Hoog, Sybren, et al.
Publicado: (2023)

Nursing Home Residents and Enterobacteriaceae Resistant to Third-Generation Cephalosporins
por: Sandoval, Carolyn, et al.
Publicado: (2004)

Human Deaths and Third-Generation Cephalosporin use in Poultry, Europe
por: Collignon, Peter, et al.
Publicado: (2013)

New definitions of susceptibility categories EUCAST 2019: clinic application
por: Díaz, Sandra G. Nabal, et al.
Publicado: (2022)

The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2023)

Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
por: Meletiadis, Joseph, et al.
Publicado: (2022)

Third-Generation Cephalosporin-Loaded Chitosan Used to Limit Microorganisms Resistance
por: Duceac, Letiția Doina, et al.
Publicado: (2020)

Identification of Salmonella Bredeney Resistant to Third-Generation Cephalosporins in Saudi Arabia
por: Al kraiem, Ayman Ahmad, et al.
Publicado: (2019)

A Rare Case of Third Generation Cephalosporin-Resistant Klebsiella Meningitis
por: Zeeshan, Adiba, et al.
Publicado: (2022)

Efficacy predictors of third-generation cephalosporins in treating spontaneous bacterial peritonitis
por: Zhu, Long-Chuan, et al.
Publicado: (2022)

Circulation of Third-Generation Cephalosporin Resistant Salmonella Typhi in Mumbai, India
por: Argimón, Silvia, et al.
Publicado: (2021)

CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole
por: Nascente, Patrícia da Silva, et al.
Publicado: (2009)

Comparison of clinical antibiotic susceptibility testing interpretations to CLSI standard interpretations
por: Hitchingham, Erin, et al.
Publicado: (2023)

A novel family VIII carboxylesterase hydrolysing third- and fourth-generation cephalosporins
por: Jeon, Jeong Ho, et al.
Publicado: (2016)

Antimicrobial Resistance Profile of Different Clinical Isolates against Third-Generation Cephalosporins
por: Gashe, Fanta, et al.
Publicado: (2018)

Emergence of Resistance to Fluoroquinolones and Third-Generation Cephalosporins in Salmonella Typhi in Lahore, Pakistan
por: Rasheed, Farhan, et al.
Publicado: (2020)

Success of ceftazidime–avibactam and aztreonam in combination for a refractory biliary infection with recurrent bacteraemia due to blaIMP-4 carbapenemase-producing Enterobacter hormaechei subsp. oharae
por: McKew, Genevieve, et al.
Publicado: (2021)

Association of Veterinary Third-Generation Cephalosporin Use with the Risk of Emergence of Extended-Spectrum-Cephalosporin Resistance in Escherichia coli from Dairy Cattle in Japan
por: Sato, Toyotaka, et al.
Publicado: (2014)

Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory
por: Guinea, Jesús
Publicado: (2020)

A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
por: Astvad, Karen Marie Thyssen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2cvai5jakhhrkqej5qhu0bgbpg